BioDelivery Sciences receives more patent protection for drug portfolio
BioDelivery Sciences International has received two new patents were granted extending patent protection around three of its Food and Drug Administration approved products.
The patented products include Belbuca buccal film, Bunavai buccal film and Onsolis.
Additionally, a patent was issued on March 21, which extends patent protection on Onsolis from January 2020 to July 2027.
BioDelivery Sciences is a specialty pharmaceutical company with a focus on pain management and addiction medicine. It is using drug delivery technologies to develop and commercialize new applications of proven therapies aimed at addressing unmet medical needs.
The U.S. rights to Onsolis are licensed to Collegium Pharmaceutical. Under the terms of the licensing agreement, the patent grant is associated with a $3 million milestone payment to BioDelivery Sciences, along with a $4 million milestone payment tied to the first commercial sale of Onsolis.
The payments are anticipated in the first half of 2018.
The Raleigh-based company reported a net loss of $15.9 million in the fourth-quarter of 2016, compared to net income of $10.2 million in the fourth quarter of 2015.
Revenue for the quarter was $3.9 million, down from the $32.2 million in revenue in the fourth quarter of 2015.
BioDelivery Sciences stock closed Friday at $1.90 per share, up 1.33 percent.
Note: This story is from the North Carolina Business News Wire, a service of UNC-Chapel Hill’s School of Media and Journalism
Please Log In to add a comment.
Latest for Insiders
- Score one for RTP: CEO explains why he bolted Silicon Valley for the Triangle
- Dr. James Goodnight, part 2: Advice on overcoming adversity, his proudest SAS memories, and the Triangle's bright future
- NC Biz Wire, PACES team, Google Fiber advocate land WRAL TechWire Editor's Choice Awards
- TechWire Awards go to six individual, six corporate Triangle tech, life science leaders
- Dr. James Goodnight: From moment of inspiration to building SAS, a global software powerhouse
- With all tickets gone, TechWire Awards to be streamed live at WRAL.com
- As Scot Wingo's new gig Spiffy lands extra $2.5M, he 'loves' being back with a startup
- Dr. Charles Hamner: A creator of NC's life science industry
- First WRAL TechWire Hall of Famers: Five pillars of NC's tech success
- Why Red Hat's new CFO left IBM - and what he likes better